Synaptosomes from hippocampus were prepared, and the LS1 fractions containing synaptic vesicles (SVs) were isolated as described previously (Zander et al., 2010). The LS1 fractions were incubated with ∗superparamagnetic beads (Dynabeads Pan Mouse IgG, Invitrogen, Life Technologies Inc., Burlington, ON, Canada) coupled to anti-synaptophysin, anti-VGLUT1 or anti-VIAAT antisera (all from Synaptic Systems, Göttingen, Germany). Beads without primary antibodies were used as negative controls. Bead-bound SVs were dissolved in Laemmli buffer, and the resultant protein pattern was analyzed by SDS-PAGE/Western blot (Zander et al., 2010) using anti-VGLUT1, anti-VIAAT, anti-synaptophysin and anti-VGLUT3 (all from Synaptic Systems, Göttingen, Germany). Immuno-signals were visualized by enhanced chemiluminescence. Densitometric analyses were performed using LabImage 1D 2006 (Kapelan Bio-Imaging Solutions) and quantified using standard curves obtained from the initial LS1 fraction.
Vesicular [3H]glutamate uptake analyses were performed as described previously (Zander et al., 2010; Frahm et al., 2015). LS1-immunoisolated SVs were bound to M-280 sheep anti-mouse beads (Invitrogen). Beads coupled with non-specific mouse IgG (Santa Cruz Biotechnologies) were used as negative controls. Uptake assays were performed with immunoisolated SVs and initiated by the addition of L-glutamate (49.5 μM, Sigma–Aldrich) and [3H]-glutamate (0.5 μM, Hartmann Analytic GmbH, Germany). Uptake was stopped after 10 min at 25°C, and unbound radioactivity was removed by centrifugation (435,000 × g, 10 min).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.